Top PGx Reporter Stories of 2012 Highlight Increasing Challenges of Personalized Medicine Market | GenomeWeb

In 2012, PGx Reporter readers were most interested in stories that reflected the growing complexity of the personalized medicine market.

PGx Reporter's most read stories last year discussed incentives affecting adoption of molecular technologies; tracked the emerging regulatory framework for drug/test combination products; chronicled the changing landscape for gene patents; and followed how life sciences companies are changing their business strategies to focus more on developing products for individualized care.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.